TROY, Mich., March 9 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) will release its financial results for the first quarter ended February 28, 2009 before the opening of the market on Wednesday, March 18, 2009. In conjunction with its financial results, the Company will host a conference call that will be webcast live at 10:00 a.m. (ET) the same day.
On the conference call, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, chief financial officer, will review Somanetics' financial results.
To listen to the webcast, visit the Webcasts and Presentations page in the Investor Relations section of Somanetics' website at www.somanetics.com prior to the event's broadcast and click on the 'Q1 2009 Somanetics Corporation Earnings Conference Call' link. Interested parties unable to listen to the live call may access the archived version of the call in the Investor Relations section of Somanetics' website.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System has an 11-year market track record supported by more than 600 clinical references, and is used at more than 700 U.S. hospitals. Somanetics recently acquired ICU Data Systems Inc., a company developing a technology that integrates data from bedside devices into a single display for comparison, data management and data storage. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit www.somanetics.com.
SOURCE Somanetics Corporation
